Literature DB >> 8206933

Expression and specificity of human GM2 activator protein.

Y Y Wu1, J M Lockyer, E Sugiyama, N V Pavlova, Y T Li, S C Li.   

Abstract

The cDNA encoding GM2 activator was expressed in the Escherichia coli/pT7-7 system. The yield of the GM2 activator with greater than 99% purity was about 3 mg per liter culture. The recombinant GM2 activator was found to be as active as that isolated from human kidney. The availability of the recombinant GM2 activator enabled us to critically examine the specificity of this activator protein. Our results show that the specificity of GM2 activator is not as strict as that reported previously. Although GM2 activator stimulates most efficiently the degradation of GM2 carried out by beta-N-acetylhexosaminidase A (Hex A), this activator also stimulates the following reactions: (a) conversion of GM2 to GA2 by clostridial sialidase; (b) hydrolysis of GalNAc from dipalmitoylphosphatidylethanolamine-II3NeuAcGgOse3 by Hex A; and (c) liberation of Gal from GM1 by beta-galactosidase at a high activator concentration. Thus, this activator does not differentiate between GM2 and dipalmitoylphosphatidylethanolamine-II3NeuAcGgOse3 or between Hex A and clostridial sialidase. The micellar forms of GD2 and GalNAc-GD1a were found to be more readily hydrolyzed by Hex A than GM2 in the absence of GM2 activator. Our results also show that saposin B can enhance the stimulatory activity of GM2 activator, but it cannot promote the stimulatory activity of sodium taurodeoxycholate. Taken together, our results suggest that the mechanism of action of GM2 activator is different from saposin B, and the action of GM2 activator is more than to solubilize lipid substrates. The effectiveness of GM2 activator in stimulating the hydrolysis of GM2 may be due to its ability to recognize the specific trisaccharide structure of the GM2 epitope, GalNAc beta 1-->4(NeuAc alpha 2-->3)Gal-, and to modify the GalNAc-NeuAc interaction in this structure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206933

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Hexosaminidase assays.

Authors:  Michaela Wendeler; Konrad Sandhoff
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

2.  Thymic involution and corticosterone level in Sandhoff disease model mice: new aspects the pathogenesis of GM2 gangliosidosis.

Authors:  Kazuhiko Matsuoka; Daisuke Tsuji; Takao Taki; Kohji Itoh
Journal:  J Inherit Metab Dis       Date:  2011-05-20       Impact factor: 4.982

3.  Synthesis and enzymatic susceptibility of a series of novel GM2 analogs.

Authors:  Tomoaki Fuse; Hiromune Ando; Akihiro Imamura; Naoki Sawada; Hideharu Ishida; Makoto Kiso; Takayuki Ando; Su-Chen Li; Yu-Teh Li
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

4.  Introduction of an N-glycan sequon into HEXA enhances human beta-hexosaminidase cellular uptake in a model of Sandhoff disease.

Authors:  Kazuhiko Matsuoka; Daisuke Tsuji; Sei-Ichi Aikawa; Fumiko Matsuzawa; Hitoshi Sakuraba; Kohji Itoh
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

5.  Degradation of G(M1) and G(M2) by mammalian sialidases.

Authors:  S C Li; Y T Li; S Moriya; T Miyagi
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

6.  Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.

Authors:  Dapeng Zhou; Carlos Cantu; Yuval Sagiv; Nicolas Schrantz; Ashok B Kulkarni; Xiaoyang Qi; Don J Mahuran; Carlos R Morales; Gregory A Grabowski; Kamel Benlagha; Paul Savage; Albert Bendelac; Luc Teyton
Journal:  Science       Date:  2003-12-18       Impact factor: 47.728

7.  Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assay.

Authors:  U Bierfreund; T Lemm; A Hoffmann; G Uhlhorn-Dierks; R A Childs; C T Yuen; T Feizi; K Sandhoff
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

8.  Design and efficient synthesis of novel GM2 analogues with respect to the elucidation of the function of GM2 activator.

Authors:  Tatsuya Komori; Takayuki Ando; Akihiro Imamura; Yu-Teh Li; Hideharu Ishida; Makoto Kiso
Journal:  Glycoconj J       Date:  2008-03-27       Impact factor: 2.916

9.  Effect of structural modifications of ganglioside GM2 on intra-molecular carbohydrate-to-carbohydrate interaction and enzymatic susceptibility.

Authors:  Yu-Teh Li; Su-Chen Li; Makoto Kiso; Hideharu Ishida; Laura Mauri; Laura Raimondi; Anna Bernardi; Sandro Sonnino
Journal:  Biochim Biophys Acta       Date:  2007-10-05

10.  Preparation of homogenous oligosaccharide chains from glycosphingolipids.

Authors:  Yu-Teh Li; Chau-Wen Chou; Su-Chen Li; Utaro Kobayashi; Yo-hey Ishibashi; Makoto Ito
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.